AptarGroup Inc ATR
News
-
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
-
Aptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
-
Daniel Ackerman Named Aptar’s Chief Accounting Officer
-
Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company
-
Aptar Reports Second Quarter 2024 Results
-
Aptar Increases Quarterly Dividend by Nearly 10% Due to Continued Strong Performance
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 30.35
- Price/Sales
- 3.00
- Dividend Yield (Trailing)
- 1.06%
- Dividend Yield (Forward)
- 1.13%
- Total Yield
- 1.40%
Company Profile
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 13,800
- Website
- https://www.aptar.com
Competitors
Valuation
|
Metric
|
ATR
|
PODD
|
WST
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.35 | 68.62 | 42.41 |
Price/Book Value | 4.39 | 16.34 | 8.45 |
Price/Sales | 3.00 | 9.37 | 7.77 |
Price/Cash Flow | 17.37 | 44.14 | 31.00 |
Price/Earnings
ATR
PODD
WST
Financial Strength
|
Metric
|
ATR
|
PODD
|
WST
|
|---|---|---|---|
Quick Ratio | 0.82 | 2.41 | 1.46 |
Current Ratio | 1.36 | 3.60 | 2.34 |
Interest Coverage | 10.92 | 7.03 | 81.96 |
Quick Ratio
ATR
PODD
WST
Profitability
|
Metric
|
ATR
|
PODD
|
WST
|
|---|---|---|---|
Return on Assets (Normalized) | 8.01% | 9.03% | 14.38% |
Return on Equity (Normalized) | 15.41% | 31.74% | 19.18% |
Return on Invested Capital (Normalized) | 10.79% | 11.10% | 16.67% |
Return on Assets
ATR
PODD
WST
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Mgwwjpwxj | Ptws | $172.9 Bil | |||
| Becton Dickinson & Co
BDX
| Ryqrqkbth | Hcyvs | $69.3 Bil | |||
| Alcon Inc
ALC
| Dpsdbpdjf | Qtrys | $49.2 Bil | |||
| ResMed Inc
RMD
| Pgwpbvfl | Rrblk | $35.1 Bil | |||
| Coloplast AS ADR
CLPBY
| Ddchrwnrsr | Kqqp | $29.2 Bil | |||
| West Pharmaceutical Services Inc
WST
| Jdqymkly | Sntp | $21.7 Bil | |||
| The Cooper Companies Inc
COO
| Vpnvcbr | Hsgypsr | $21.5 Bil | |||
| Hologic Inc
HOLX
| Lvqvwwrnj | Fqqhk | $18.5 Bil | |||
| Baxter International Inc
BAX
| Mgpmzhxwb | Pwwstb | $18.4 Bil | |||
| Align Technology Inc
ALGN
| Ftdmxvqt | Jvydndn | $17.8 Bil |
United States